Giant cell arteritis: pathogenic mechanisms and new potential therapeutic targets

Giant cell arteritis (GCA) is the most common idiopathic systemic vasculitis in persons aged 50 years or greater. Treatment options for GCA, to-date, have been limited and have consisted primarily of glucocorticoids. Significant advances in the understanding of the genetic and cellular mechanisms in...

Descripción completa

Detalles Bibliográficos
Autores principales: Koster, Matthew J., Warrington, Kenneth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383596/
https://www.ncbi.nlm.nih.gov/pubmed/30886946
http://dx.doi.org/10.1186/s41927-017-0004-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383596/
https://www.ncbi.nlm.nih.gov/pubmed/30886946
http://dx.doi.org/10.1186/s41927-017-0004-5

Ejemplares similares